Evidence map›Paper›PMID 40028183›Full record

ArticleFrontiers in cellular and infection microbiology2025

Enhanced invasion and survival of antibiotic- resistant

Kathleen Klaper, Yvonne Pfeifer, Lena Heinrich, Marcel Prax, Oleg Krut, Isabelle Bekeredjian-Ding, Anika Wahl, Martin A Fischer, Heike Kaspar, Stefan Borgmann and 2 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathleen KlaperDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Yvonne PfeiferDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Lena HeinrichDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Marcel PraxDivision of Microbiology, Paul Ehrlich Institute, Langen, Germany.
Oleg KrutDivision of Microbiology, Paul Ehrlich Institute, Langen, Germany.
Isabelle Bekeredjian-DingDivision of Microbiology, Paul Ehrlich Institute, Langen, Germany.
Anika WahlDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Martin A FischerDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Heike KasparDivision of Antibiotic Resistance Monitoring, Federal Office of Consumer Protection and Food Safety, Berlin, Germany.
Stefan BorgmannDepartment of Infectious Diseases and Infection Control, Hospital Ingolstadt, Ingolstadt, Germany.
Roman G GerlachDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Guido WernerDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Results: Significant differences in adhesion and invasion capability, phagocytosis resistance and intracellular replication were measured between different Conclusion: Our

Indexed as

Drug Resistance, BacterialHost-Pathogen InteractionsKlebsiella InfectionsKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsBacterial AdhesionBlood PlateletsCell LineEpithelial CellsHumansMacrophagesMicrobial ViabilityPhagocytosisSiderophoresVirulenceAnti-Bacterial AgentsSiderophoresadhesioncell morphologyinvasionKlebsiella pneumoniaenormoxiaplatelet concentratereplicationserum resistance

Identifiers

PMID40028183
PMCPMC11868097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.